SIMBRINZA
- Product NDC
- 0078-0904
- 11-digit product format
- 000780904
- Labeler code
- 0078
- Product ID
- 0078-0904_c2a9e73d-9414-489a-9840-aa8aae4cdd00
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brinzolamide/brimonidine tartrate
- Dosage form
- SUSPENSION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA204251
- Marketing category
- NDA
- Marketing start
- 2013-05-01
- Marketing end
- 2023-02-28
- Substance
- BRIMONIDINE TARTRATE; BRINZOLAMIDE
- Active strength
- 2 mg/mL; mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0904-38 | 00078090438 | 1 BOTTLE in 1 CARTON (0078-0904-38) > 8 mL in 1 BOTTLE | 1 bottle | 2020-08-04 | 0000-00-00 | No | No | Current |
| 0078-0904-98 | 00078090498 | 1 BOTTLE in 1 CARTON (0078-0904-98) > 2.5 mL in 1 BOTTLE | 1 bottle | 2020-08-04 | 0000-00-00 | Yes | No | Current |